Table 1.
Characteristics of pregnancies from patients with pre-existing hypertension, MarketScan® commercial claims databases, 2011–2020.
Table 2.
Prevalence of antihypertensive medication exposure before, during, and after pregnancy by class, live birth only (N = 12,978).
Fig 1.
Transition of antihypertensive exposure from pre-pregnancy to the first trimester (A) and from the first trimester to the second trimester (B) among patients with exposures to certain classes of antihypertensives, live birth only.
Fig 2.
Initial medication choices among initiators by pregnancy-related period, live birth only.
Fig 3.
Temporal trends in antihypertensive utilization by pregnancy-related periods, live birth only.